These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 37298405

  • 1. Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation.
    Wu M, Song D, Li H, Ahmad N, Xu H, Yang X, Wang Q, Cheng X, Deng S, Shu X.
    Int J Mol Sci; 2023 May 29; 24(11):. PubMed ID: 37298405
    [Abstract] [Full Text] [Related]

  • 2. Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment.
    Das A, Alshareef M, Porto GBF, Infinger LK, Vandergrift WA, Lindhorst SM, Varma AK, Patel SJ, Cachia D.
    J Neurol Sci; 2020 Nov 15; 418():117102. PubMed ID: 32866816
    [Abstract] [Full Text] [Related]

  • 3. Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    Yamada T, Tsuji S, Nakamura S, Egashira Y, Shimazawa M, Nakayama N, Yano H, Iwama T, Hara H.
    J Neurosurg; 2021 Mar 01; 134(3):701-710. PubMed ID: 32168477
    [Abstract] [Full Text] [Related]

  • 4. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
    Lombardi F, Augello FR, Artone S, Gugu MK, Cifone MG, Cinque B, Palumbo P.
    Int J Mol Sci; 2022 Jan 28; 23(3):. PubMed ID: 35163465
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O6-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma.
    Jin L, Kiang KM, Cheng SY, Leung GK.
    Lab Invest; 2022 Feb 28; 102(2):194-203. PubMed ID: 34625658
    [Abstract] [Full Text] [Related]

  • 6. NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells.
    Tsuji S, Nakamura S, Shoda K, Yamada T, Shimazawa M, Nakayama N, Iwama T, Hara H.
    J Neurooncol; 2022 Nov 28; 160(2):375-388. PubMed ID: 36308592
    [Abstract] [Full Text] [Related]

  • 7. Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells.
    Taspinar M, Ilgaz S, Ozdemir M, Ozkan T, Oztuna D, Canpinar H, Rey JA, Sunguroğlu A, Castresana JS, Ugur HC.
    Tumour Biol; 2013 Jun 28; 34(3):1935-47. PubMed ID: 23519841
    [Abstract] [Full Text] [Related]

  • 8. STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression.
    Kohsaka S, Wang L, Yachi K, Mahabir R, Narita T, Itoh T, Tanino M, Kimura T, Nishihara H, Tanaka S.
    Mol Cancer Ther; 2012 Jun 28; 11(6):1289-99. PubMed ID: 22532597
    [Abstract] [Full Text] [Related]

  • 9. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 28; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

  • 10. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma.
    Wu S, Li X, Gao F, de Groot JF, Koul D, Yung WKA.
    Neuro Oncol; 2021 Jun 01; 23(6):920-931. PubMed ID: 33433610
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.
    Zhao J, Yang S, Cui X, Wang Q, Yang E, Tong F, Hong B, Xiao M, Xin L, Xu C, Tan Y, Kang C.
    Neuro Oncol; 2023 May 04; 25(5):857-870. PubMed ID: 36272139
    [Abstract] [Full Text] [Related]

  • 13. EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT.
    Xin L, Tan Y, Zhu Y, Cui X, Wang Q, Zhao J, Tian S, Xu C, Xiao M, Hong B, Xu J, Yuan X, Wang C, Kang C, Fang C.
    Neuro Oncol; 2023 Nov 02; 25(11):1976-1988. PubMed ID: 37279651
    [Abstract] [Full Text] [Related]

  • 14. Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT).
    Yousefi Y, Nejati R, Eslahi A, Alizadeh F, Farrokhi S, Asoodeh A, Mojarrad M.
    J Neurooncol; 2024 Aug 02; 169(1):129-135. PubMed ID: 38762829
    [Abstract] [Full Text] [Related]

  • 15. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
    Hu YH, Jiao BH, Wang CY, Wu JL.
    CNS Neurosci Ther; 2021 May 02; 27(5):552-563. PubMed ID: 33460245
    [Abstract] [Full Text] [Related]

  • 16. Temozolomide Induces the Acquisition of Invasive Phenotype by O6-Methylguanine-DNA Methyltransferase (MGMT)+ Glioblastoma Cells in a Snail-1/Cx43-Dependent Manner.
    Kochanowski P, Catapano J, Pudełek M, Wróbel T, Madeja Z, Ryszawy D, Czyż J.
    Int J Mol Sci; 2021 Apr 16; 22(8):. PubMed ID: 33923767
    [Abstract] [Full Text] [Related]

  • 17. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z, Wei X, Shen L, Zhu H, Zheng X.
    Cancer Sci; 2019 Jan 16; 110(1):389-400. PubMed ID: 30431207
    [Abstract] [Full Text] [Related]

  • 18. Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p.
    Wu P, Cai J, Chen Q, Han B, Meng X, Li Y, Li Z, Wang R, Lin L, Duan C, Kang C, Jiang C.
    Nat Commun; 2019 May 03; 10(1):2045. PubMed ID: 31053733
    [Abstract] [Full Text] [Related]

  • 19. Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.
    Yang B, Ma YB, Chu SH.
    Cancer Gene Ther; 2018 Dec 03; 25(11-12):309-316. PubMed ID: 30140041
    [Abstract] [Full Text] [Related]

  • 20. SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT.
    Tsai CK, Huang LC, Wu YP, Kan IY, Hueng DY.
    FASEB J; 2019 Dec 03; 33(12):14171-14184. PubMed ID: 31725331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.